GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $91,000 | +127.5% | 1,145 | +36.6% | 0.00% | – |
| Q3 2019 | $40,000 | -93.3% | 838 | -92.7% | 0.00% | -100.0% |
| Q2 2019 | $600,000 | +1295.3% | 11,404 | +1307.9% | 0.01% | – |
| Q1 2019 | $43,000 | +53.6% | 810 | +15.7% | 0.00% | – |
| Q4 2018 | $28,000 | -22.2% | 700 | -26.1% | 0.00% | – |
| Q3 2018 | $36,000 | -47.1% | 947 | -36.9% | 0.00% | -100.0% |
| Q2 2018 | $68,000 | -34.6% | 1,500 | -30.4% | 0.00% | 0.0% |
| Q1 2018 | $104,000 | +65.1% | 2,155 | +34.7% | 0.00% | 0.0% |
| Q4 2017 | $63,000 | +16.7% | 1,600 | -8.6% | 0.00% | 0.0% |
| Q3 2017 | $54,000 | +5300.0% | 1,750 | +6900.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |